Local generic drug maker Mylan this morning formally launched its hostile takeover bid for Perrigo Co. by asking Perrigo shareholders to tender their shares.
Mylan, which announced last week that it would be making the move today, is offering $75 in cash and 2.3 shares for each of Perrigo's shares.
Under terms of the offer, which was rejected by Perrigo's board in April, Perrigo shareholders would own about 40 percent of the combined company.
"Shareholders are strongly advised to take no action in relation to the offer at this time pending the board's review," Perrigo said in a statement this morning.
The Ireland-based over-the-counter drug specialist said it would issue a recommendation within 10 business days through a filing with the Securities and Exchange Commission.
Irish takeover rules prohibit Perrigo from commenting on Mylan's formal offer until after the SEC filing.
Read More
Mylan, which continues to be operated from Cecil after reincorporating in the Netherlands this year, said its offer is set to expire Nov. 13.
Patricia Sabatini: PSabatini@post-gazette.com; 412-263-3066.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.